EUVIMEDEUVIMED entdecken
Crossref

Plasma Interleukin 22 Predicts Progression of Early Diabetic Kidney Disease

Beatriz Fernandez-Fernandez, Takehiro Hasegawa, Yuko Saruta, Yun Li Guan, Ana Belen Sanz, Maria Dolores Sanchez-Niño, Adrian M Ramos, Jinny Sanchez-Rodriguez, Juan Francisco Navarro-Gonzalez, Alberto Ortiz

American Journal of Nephrology · 2025

DOI: 10.1159/000547738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Beatriz Fernandez-Fernandez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, bfernandez@fjd.es. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Interleukins, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The residual risk of chronic kidney disease (CKD) progression remains high in clinical trials of kidney protective drugs in patients with diabetic kidney disease (DKD).

Methods

In a prospective study, we assessed whether 16 plasma and 10 urine cytokine levels can inform the residual risk of CKD progression in 93 incident patients with DKD treated by nephrology according to clinical guidelines.

Results

Plasma and urine levels of 12 plasma and 7 urinary cytokines differed between patients with DKD and from healthy controls. Participants were categorized into CKD G1–G2 (preserved GFR) and CKD G3–G5 (GFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesInterleukinsRenal Insufficiency, ChronicHumansDisease ProgressionMaleFemaleProspective StudiesMiddle AgedBiomarkersInterleukin-22Glomerular Filtration RateTumor Necrosis Factor-alphaAged

Stichwörter der Autor:innen

Chronic kidney diseaseCytokinesDiabetes mellitusDiabetic kidney diseaseInterleukin 22Protein biomarker

Substanzen

InterleukinsBiomarkersInterleukin-22Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Departamento de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, bfernandez@fjd.es.
  • RICORS2040-Renal, ISCIII, Madrid, Spain, bfernandez@fjd.es.
  • Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain, bfernandez@fjd.es.
  • Sysmex R&D Center Europe GmbH, Hamburg, Germany.
  • Departamento de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain.
  • RICORS2040-Renal, ISCIII, Madrid, Spain.

Zitieren

APA

Fernandez-Fernandez, B., Hasegawa, T., Saruta, Y., Li Guan, Y., Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Sanchez-Rodriguez, J., Navarro-Gonzalez, J. F., & Ortiz, A. (2025). Plasma Interleukin 22 Predicts Progression of Early Diabetic Kidney Disease. American Journal of Nephrology. https://doi.org/10.1159/000547738

Vancouver

Fernandez-Fernandez B, Hasegawa T, Saruta Y, Li Guan Y, Sanz AB, Sanchez-Niño MD, et al. Plasma Interleukin 22 Predicts Progression of Early Diabetic Kidney Disease. American Journal of Nephrology. 2025. doi:10.1159/000547738

BibTeX
@article{FernandezFernandez2025,
  author = {Fernandez-Fernandez, Beatriz and Hasegawa, Takehiro and Saruta, Yuko and Li Guan, Yun and Sanz, Ana Belen and Sanchez-Niño, Maria Dolores and Ramos, Adrian M and Sanchez-Rodriguez, Jinny and Navarro-Gonzalez, Juan Francisco and Ortiz, Alberto},
  title = {Plasma Interleukin 22 Predicts Progression of Early Diabetic Kidney Disease},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000547738}
}
Kostenlos starten →